17.11.2015
- US-based drugs firm Janssen Pharmaceuticals has gained worldwide rights, excluding China and Korea, to develop and commercialize oxyntomodulin-based treatments for diabetes and...
16.10.2015
- Canada’s enGne, a gene therapy company focused on development of therapeutics using its proprietary “Gene Pill”, and Janssen Biotech, one of the Janssen Pharmaceutical Companies of...
22.09.2015
- Bavarian Nordic, a Danish biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases, has...
28.06.2015
- Janssen Pharmaceuticals, subsidiary of Johnson & Johnson, has donated $6 million to Rutgers University in the US to fund ongoing research into continuous manufacturing – an...
28.05.2015
- AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...
21.05.2015
- Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...
27.02.2015
- The Supreme Court of the US state of South Carolina has ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had...
07.01.2015
- US over-the-counter drugmaker Johnson & Johnson will pay Isis Pharmaceuticals up to $835 million for the option to license three drugs targeting autoimmune diseases in the bowel...
